Identification and characterization of transmissible Pseudomonas aeruginosa strains in cystic fibrosis patients in England and Wales.

Most past studies of cross-infection with Pseudomonas aeruginosa among cystic fibrosis (CF) patients in the UK suggest that it is a rare occurrence. However, two recent reports of highly transmissible strains in patients in regional centres in England (Liverpool and Manchester) have raised questions as to the extent of the problem and prompted a nationwide survey to establish the distribution of P. aeruginosa strain genotypes among these patients. Isolates of P. aeruginosa were requested from over 120 hospitals in England and Wales and a sample size of approximately 20% of the CF patient population in each centre was recommended. In total, 1225 isolates were received from 31 centres (range 1 to 330). Single patient isolates were typed by SpeI macrorestriction and PFGE. A panel of strains of the common genotypes including representatives of reported transmissible strains was assembled and further characterized by fluorescent amplified fragment length polymorphism (FAFLP) genotyping. At least 72% of all patients harboured strains with unique genotypes. Small clusters of related strains were evident in some centres, presumably indicating limited transmission of local strains. The most prevalent strain was indistinguishable from that previously described as the 'Liverpool' genotype, and accounted for approximately 11% of patient isolates from 15 centres in England and Wales. The second most common genotype (termed Midlands 1) was recovered from 86 patients in nine centres and the third genotype, which matched closely the PFGE profile of Clone C, a genotype originally described in Germany, was found in eight centres and was isolated from 15 patients. A fourth genotype, identical to the published Manchester strain, was found in three centres. FAFLP analysis revealed some microheterogeneity among strains of the Liverpool genotype but all isolates of this genotype were positive by PCR for a strain-specific marker. These data suggest that cross-infection with P. aeruginosa has occurred both within and widely between CF centres in England and Wales. The two most common genotypes accounted for more than one-fifth of patients' isolates examined and transmissible genotypes were found in all but three centres studied. These results emphasize the need for continued surveillance of P. aeruginosa genotypes in CF patients to provide informed infection control policy in treatment centres.

[1]  M. Walshaw,et al.  Superinfection with a transmissible strain of Pseudomonas aeruginosa in adults with cystic fibrosis chronically colonised by P aeruginosa , 2001, The Lancet.

[2]  M. Dodd,et al.  Identification of airborne dissemination of epidemic multiresistant strains of Pseudomonas aeruginosa at a CF centre during a cross infection outbreak. , 2003, Thorax.

[3]  C. Hart,et al.  Use of Subtractive Hybridization To Identify a Diagnostic Probe for a Cystic Fibrosis Epidemic Strain of Pseudomonas aeruginosa , 2002, Journal of Clinical Microbiology.

[4]  M. P. Cummings.  PHYLIP (Phylogeny Inference Package) , 2004 .

[5]  M. Bonten,et al.  Application of Different Genotyping Methods forPseudomonas aeruginosa in a Setting of Endemicity in an Intensive Care Unit , 1999, Journal of Clinical Microbiology.

[6]  A. Vanderkelen,et al.  Pseudomonas aeruginosa displays an epidemic population structure. , 2002, Environmental microbiology.

[7]  M. Hodson,et al.  Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. , 2000, The European respiratory journal.

[8]  M. Kaufmann,et al.  Pulsed-field gel electrophoresis. , 1998, Methods in molecular medicine.

[9]  J. Carlin,et al.  Detection of a widespread clone of Pseudomonas aeruginosa in a pediatric cystic fibrosis clinic. , 2002, American journal of respiratory and critical care medicine.

[10]  M. Dodd,et al.  Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic , 2001, The Lancet.

[11]  T. Pitt,et al.  Discriminatory power of three DNA-based typing techniques for Pseudomonas aeruginosa , 1995, Journal of clinical microbiology.

[12]  E. Mahenthiralingam,et al.  Epidemiology of Pseudomonas aeruginosa in cystic fibrosis in British Columbia, Canada. , 2002, American journal of respiratory and critical care medicine.

[13]  A. MacGowan,et al.  Establishing MIC breakpoints and the interpretation of in vitro susceptibility tests. , 2001, The Journal of antimicrobial chemotherapy.

[14]  C. Winstanley,et al.  Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic , 1996, The Lancet.

[15]  J. Elion,et al.  Genetic heterogeneity of Pseudomonas aeruginosa clinical isolates revealed by esterase electrophoretic polymorphism and restriction fragment length polymorphism of the ribosomal RNA gene region. , 1994, Journal of medical microbiology.

[16]  B. Tümmler,et al.  A major Pseudomonas aeruginosa clone common to patients and aquatic habitats , 1994, Applied and environmental microbiology.

[17]  M. Denton,et al.  Spread of β-lactam-resistant Pseudomonas aeruginosa in a cystic fibrosis clinic , 1996 .

[18]  E. Holmes,et al.  Recombination within natural populations of pathogenic bacteria: short-term empirical estimates and long-term phylogenetic consequences. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Dodd,et al.  Increased treatment requirements of patients with cystic fibrosis who harbour a highly transmissible strain of Pseudomonas aeruginosa , 2002, Thorax.

[20]  D. Livermore,et al.  Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[21]  T. Pitt,et al.  European-wide distribution of Pseudomonas aeruginosa clone C. , 2003, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[22]  J. Threlfall,et al.  Genetic structure of Salmonella revealed by fragment analysis. , 2002, International journal of systematic and evolutionary microbiology.

[23]  J. Elion,et al.  The absence of correlation between allozyme and rrn RFLP analysis indicates a high gene flow rate within human clinical Pseudomonas aeruginosa isolates. , 1993, FEMS microbiology letters.

[24]  B. Tümmler,et al.  Sequence Diversity of Pseudomonas aeruginosa: Impact on Population Structure and Genome Evolution , 2000, Journal of bacteriology.